This is where it gets tricky. For anyone wanting to enter the BNPL space wanting capital growth, they won't bother with FXL. Also, no one really wants to enter the BNPL space for dividends (perhaps the one sole trump card that FXL holds)... So thats why they are in an odd position.
For what it's worth I still think FXL will do well, and outperform the market due to the growth in BNPL, I just don't think they'll be able to keep up with peers in terms of capital growth. The land grab is happening. BNPL is being adopted worldwide in unprecedented speed, with COVID-19 being a catalyst. So it's all about going out there and being part of the land grab, getting your hands into as many pies as possible so that future growth is secure. That's what Klarna, APT and Z1P are doing very well at the moment.
Anyway, I repeat, FXL should do just fine imo, but holders should just lower your expectations a little and try not to compare growth to peers. AIMO
- Forums
- ASX - By Stock
- HUM
- Buckle up for $2
Buckle up for $2, page-1467
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HUM (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
0.015(3.33%) |
Mkt cap ! $226.0M |
Open | High | Low | Value | Volume |
45.0¢ | 46.5¢ | 45.0¢ | $171.8K | 376.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 99839 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 38835 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 99899 | 0.460 |
5 | 123672 | 0.455 |
2 | 20595 | 0.450 |
2 | 55529 | 0.445 |
2 | 12482 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 38862 | 6 |
0.470 | 37696 | 5 |
0.475 | 16594 | 4 |
0.480 | 93369 | 3 |
0.485 | 20500 | 1 |
Last trade - 14.55pm 15/07/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online